![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Gedeon Richter Plc Budapest Hu, based in Hungary, is a pharmaceutical company.
One of their significant offerings is Lisinopril dihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1999-051 - Rev 03
This Chemical Type CEP, issued on March 23, 2011, remains in force until April 16, 2015, ensuring its reliability within the pharmaceutical industry.
Substance Number 1120 associated with this CEP further emphasizes